{ "items": [ "\n\n
\n \n 12 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nA UK trial of drugs which could prevent people aged over 50 who are vulnerable to developing serious coronavirus symptoms is now recruiting participants from across the country.
\n \n\n\n \n 1 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nThe SEBCOV study aims to produce evidence to inform public health measures such as communications, quarantine, self-isolation, social distancing, and travel restrictions for the COVID-19 pandemic. This study is run in four countries: UK, Thailand, Italy and Malaysia.
\n \n\n\n \n 27 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 20 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from Nuffield Department of Primary Care Health Sciences are now enrolling participants into PRINCIPLE, the first clinical trial of potential COVID-19 treatments to take place in GP practices.
\n \n\n\n \n 23 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from Nuffield Department of Medicine and Nuffield Department of Population Health have launched a new clinical trial to test the effects of potential drug treatments for patients admitted to hospital with COVID-19. The first patients have now been recruited.
\n \n\n\n \n 6 August 2018\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 18 July 2018\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University Hospitals NHS Foundation Trust has risen to the top of a table for the most patients recruited to take part in research studies.
\n \n\n\n \n 12 April 2018\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNewKI, one of UK\u2019s largest observational studies of incident chronic kidney disease (CKD) in general practice, gets underway this month, involving 3,205 Oxfordshire residents and led by Oxford University researchers.
\n \n\n\n \n 28 March 2018\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers are working with schools around the county to find 24,000 volunteers aged 16 to 18 years to take part in the Be on the TEAM (Teenagers Against Meningitis) trial, led by the Oxford Vaccine Group at the Oxford University's Paediatrics Department with funding and support from the National Institute for Health Research (NIHR).
\n \n\n\n \n 19 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe world\u2019s first NHS trial for a universal flu vaccine has recruited its first round of participants, with over 862 people signing up to take part since the trial launched in October 2017.
\n \n\n\n \n 3 October 2017\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe world\u2019s first widespread human testing of a flu vaccine which researchers hope will protect more over 65-year-olds against influenza has begun in the NHS.
\n \n\n